NCT00831987 Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® Vaccine Status COMPLETED Phase PHASE4
NCT00831675 Study of Safety and Immunogenicity of Fluzone® in Healthy Children Status COMPLETED Phase PHASE4
NCT00828100 Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B Status SUSPENDED Phase PHASE3
NCT00825162 Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years Status COMPLETED Phase PHASE4
NCT00819013 Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults Status COMPLETED Phase PHASE1
NCT00814385 Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04 Status COMPLETED Phase PHASE1/PHASE2
NCT00814229 Safety and Immunogenicity of Influenza H9 Vaccine in Humans Status COMPLETED Phase PHASE1
NCT00812981 A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine. Status COMPLETED Phase PHASE3
NCT00812110 Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home Status COMPLETED Phase PHASE4
NCT00812019 Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old) Status COMPLETED Phase PHASE1
NCT00800605 Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection Status COMPLETED Phase PHASE3
NCT00798343 Heterosubtypic Immune Responses to Influenza in Older People Status COMPLETED Phase PHASE1
NCT00783926 Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant) Status COMPLETED Phase PHASE1
NCT00782431 Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older Status COMPLETED Phase PHASE3